Related Party Transactions and Outside Related Director Information

Stratagene Corporation (STGN)

4/11/2006 Proxy Information

During fiscal year 2005, the following relationships and related transactions with any Stratagene officer or director took place:

The Burnham Institute, whose CEO is John C. Reed (who is also a director of Stratagene), purchased reagent products from Stratagene during 2005 in the aggregate amount of approximately $84,000. Additionally, Carlton J. Eibl, who is also a director of Stratagene, was the chairman of the board of trustees for the Burnham Institute until September 2005.

There were no other relationships and/or related transactions with Stratagene officers or directors for fiscal year 2005.